|
Characteristics Patients (n = 16) |
Data |
|---|---|
| Female n | 14 |
| Male n | 2 |
| Age (years), mean (min-max) | 53 (32 – 73) |
| Disease Duration (years), mean (range) | 10 (±7,9) |
|
DAS28 (%) Low Disease Activity (≤3.2) Moderate and High Disease Activity (>3.2) |
9 (56%) 7 (44%) |
|
CDAI (%) Low Disease Activity (≤ 10) Moderate and High Disease Activity (> 10) |
8 (50%) 8 (50%) |
|
Treatment (%)* None Prednisone Methotrexate Leflunomide |
3 9 11 2 |
| ESR mean (range mm/h) | 16 (±10) |
| Rheumatoid Factor (%) | 16 (100%) |
| * Eight patients were on Prednisone and Methotrexate combination and only one on Leflunomide and Methotrexate combination. | |